Role for tyrosine phosphorylation and lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils

Blood

Volumn 92, Issue 2, 1998, Pages 547-557

  Simon, Hans Uwe ^a   Yousefi, Shida ^b   Dibbert, Birgit ^c   Hebestreit, Holger ^d   Weber, Martina ^c   Branch, Donald R ^a   Blaser, Kurt ^b   Levi Schaffer, Francesca ^a   Anderson, Gary P ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Canadian Red Cross Society   (Canada)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; EOSINOPHILIA; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032528488     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.2.547.414k02_547_557     Document Type: Article

References (91)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233,1991
2. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274,1992
3. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
4. Cleveland JL, Ihle, JN: Contenders in FasUTNF death signaling. Cell 81:479,1995
5. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P: TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 181:781, 1995
6. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-l/(Fas/CD95). Nature 373:438,1995
7. Brunner T, Mogli RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cellautonomous Fas (CD95)/Fas-ligand interaction mediates activation, induced apoptosis inT-cell hybridomas. Nature 373:441,1995
8. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444,1995
9. Simon HU, Yousefi S, Dommann-ScherrerCC, Zimmermann DR, Bauer S, Barandun J, Blaser K: Expansion of cytokine-producing CD4~CD8~ T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 183:1071,1996
10. Matsumoto K, Schleimer RP, Saito H, likura Y, Bochner BS: Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437,1995
11. Tsuyuki S, Bertrand C, Erard F, TrifilieffA, Tsuyuki J, Wesp M, Anderson GP, Coyle AJ: Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 96:2924, 1995
12. Druilhe A, Cai Z, Hailé S, Chouaib S, Pretolani M: Fas-mediated apoptosis in cultured human eosinophils. Blood 87:2822,1996
13. Hebestreit H, Yousefi S, Balatti I, Weber M, Crameri R, Simon D, Härtung K, Schapowal A, Blaser K, Simon HU: Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol 26:1775,1996
14. Hunter T: Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80:225,1995
15. Eischen CM, Dick CJ, Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947,1994
16. 16. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: Fas-induced apoptosis is mediated via a ceramideinitiated RAS signaling pathway. Immunity 2:341, 1995
17. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429,1996
18. Wang J, Koizumi T, Watanabe T: Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyndeficient mice. J Exp Med 184:831,1996
19. Gradl G, Grandison P, Lindridge E, Wang Y, Watson J, Rudert F: The CD95 (Fas/APO-1) receptor is phosphorylated in vitro and in vivo and constitutively associates with several cellular proteins. Apoptosis 1:131,1996
20. Mollereau B, Decken M, Déas O, Rieux-Laucat F, Hirsch F, Bernard A, Fischer A, Lynch DH, Charpentier B, Le Deist F, Senik A: CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol 156:3184,1996
21. Schulze-Osthoff K, Krammer PH, Droge W: Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13:4587,1994
22. Schraven B, Peter ME: APO-l(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett 368:491, 1995
23. Latinis KM, Koretzky GA: Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871,1996
24. Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD: Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2:353, 1995
25. Su X, Zhou T, Yang PA, Wang Z, Mountz JD: Hematopoietic cell protein-tyrosine phosphatase-deficient Motheaten mice exhibit T cell apoptosis defect. J Immunol 156:4198,1996
26. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411,1995
27. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301,1989
28. Simon HU, Tsao PW, Siminovitch KA, Mills GB, Blaser K: Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol 153:364,1994
29. Yousefi S, Green DR, Blaser K, Simon HU: Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sei USA91:10868,1994
30. Yousefi S, Hemmann S, Weber M, Hölzer C, Härtung K, Blaser K, Simon HU: IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 154:5481, 1995
31. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 183:1407, 1996
32. Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA, Budd RC: JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26:989, 1996
33. Wei S, Liu JH, Epling-Burnette PK, Gamero AM, Ussery D, Pearson EW, Elkabani ME, Diaz JI, Djeu J Y: Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colonystimulating factor. J Immunol 157:5155,1996
34. Coyle AJ, Le Gros G, Bertrand C, Tsukuki S, Heusser CH, Kopf M, Anderson GP: IL-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 13:54,1995
35. Coyle AJ, Tsuyuki S, Bertrand C, Huang S, Aguet M, Alkan SS, Anderson GP: Mice lacking the IFN-v receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol 156:2680,1996
36. Simon HU: Novel therapeutic strategies via the apoptosis pathways to resolve chronic eosinophilic inflammation. Cell Death Diff 3:349,1996
37. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195,1996
38. Fraser A, Evan, G: A license to kill. Cell 85:781,1996
39. Weaver VM, Carson CE, Walker PR, Chaly N, Lach B, Raymond Y, Brown DL, Sikorska M: Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J Cell Science 109:45,1996
40. Rao L, Perez D, White E: Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135:1441,1996
41. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC: Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sei US A 92:9042,1995
42. Earnshaw WC: Nuclear changes in apoptosis. Curr Opin Cell Biol 7:337,1995
43. Dharminder C, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fasinduced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89:227,1997
44. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH, Nordheim A: CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13:2087, 1996
45. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R: The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEKmicrotubule-associated protein kinase pathway. J Exp Med 181:1827, 1995
46. Pazdrak K, Justement L, Alam R: Mechanism of inhibition of eosinophil activation by transforming growth factor-. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 155:4454,1995
47. Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sei US A 91:4683, 1994
48. Gaudry M, Gilbert C, Barabé F, Poubelle PE, Naccache PH: Activation of Lyn is a common element of the stimulation of human neutrophils by soluble and particulate agonists. Blood 86:3567,1995
49. Scheuermann RH, Racila E, Tucker T, Yefenof E, Street NE, Vitetta ES, Picker LJ, Uhr JW: Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc Natl Acad Sei USA91:4048,1994
50. Bousquet J, Chanez P, Lacoste JY, Bameon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 323:1033, 1990
51. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 13:501,1992
52. Seminario MC, Gleich GJ: The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 6:860,1994
53. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP: Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 153:2153, 1994
54. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty DF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:881, 1994
55. Ponath PD, Qin S, Ringler DJ, dark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, New-man W, Gutierrez-Ramos JC, Mackay CR: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97:604,1996
56. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CDll/18)-dependent manner. Int Arch Allergy Appl Immunol 94:174, 1991
57. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman V, Luscinskas FW, Gimbrone MA, Mclntyre BW, Bochner BS: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-l.J Immunol 148:1086,1992
58. Moser R, Fehr J, Olgiati L, Bruijnzeel PLB: Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 79:2937, 1992
59. Neeley SP, Hamann KJ, White SR, Baranowski SL, Burch RA, Leff AR: Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils. Am J Respir Cell Mol Biol 8:633,1993
60. Knol EF, lackey F, Tedder TF, Klunk DA, Bickel CA, Sterbinsky SA, Bochner BS: Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. Role of L-selectin. J Immunol 153:2161,1994
61. FukudaT,FukushimaY,NumaoT.AndoN,ArimaM,Nakajima H, Sagara H, Adachi T, Motojima S, Makino S: Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 14:84, 1996
62. Owen VF, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF, Soberman RJ: Regulation of human eosinophil viability, density, and function by granulocyte-macrophage colonystimulating factor in the presence of 3T3 fibroblasts. J Exp Med 166:129,1987
63. Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 81:1986,1988
64. Rothenberg ME, Stevens RL, Silberstein DS, Soberman R, Austen KF, Owen WF: IL-5 promotes long-term culture and enhances functional properties of human eosinophils. J Immunol 143:2311, 1989
65. Her E, Frazer J, Austen KF, Owen WF: Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 88:1982,1991
66. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542, 1991
67. Stem M, Meagher L, Savill J, Haslett C: Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 148:3543, 1992
68. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158:3902,1997
69. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME: Cytotoxicity-dependent APO-1 (Fas/CD95)associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBOJ 14:5579,1995
70. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APOl contains a sequence motif related to the death domain. J Biol Chem 270:7795,1995
71. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505,1995
72. Boldin M, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1and TNF receptor-induced cell death. Cell 85:803,1996
73. Muzio M., Chinnaiyan AM, Kischkel FC, O'Rourke R, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817,1996
74. Hess S, Engelmann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 183:159,1996
75. Ren CL, Mono T, Fu SM, Geha RS: Signal transduction via CD40 involves activation of Lyn kinase and phosphatidylinositol-3kinase, and phosphorylation of phospholipase C-y2. J Exp Med 179:673, 1994
76. Paris M, Gaskin F, Parsons JT, Fu SM: CD40 signaling pathway: Anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J Exp Med 179:1923,1994
77. Gulbins E, Brenner B, Schlottmann K, Koppenhoefer U, Linderkamp O, Coggeshall KM, Lang F: Activation of the Ras signaling pathway by the CD40 receptor. J Immunol 157:2844,1996
78. Dusi S, Bianca VD, Donini M, Nadalini KA, Rossi F: Mechanisms of stimulation of the respiratory burst by TNF in nonadherent neutrophils. Its independence of lipidic transmembrane signaling and dependence on protein tyrosine phosphorylation and cytoskeleton. J Immunol 157:4615,1996
79. Weber C, Negrescu E, Er! W, Pietsch A, Frankenberger M, Ziegler-Heitbrock HWL, Siess W, Weber PC: Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 155:445, 1995
80. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067, 1997
81. Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, Ulevitch RJ, Nemerow GR, Han J: Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6:739,1997
82. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Nature 270:1326,1995
83. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75,1996
84. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800,1996
85. Kolesnick R, Fuks Z: Ceramide: A signal for apoptosis or mitogenesis?JExpMed 181:1949,1995
86. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sei USA 88:3314,1991
87. Taieb J, Blanchard DA, Auffredou MT, Chaouchi N, Vazquez A: In vivo association between p561ck and MAP kinase during IL-2mediated lymphocyte proliferation. J Immunol 155:5623,1995
88. Gomez J, Martinez-A C, Fernandez B, Garcia A, Rebollo A: Ras activation leads to cell proliferation or apoptotic cell death upon interIeukin-2 stimulation or lymphokine deprivation, respectively. Eur J Immunol 27:1610,1997
89. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T-Iymphocytes. J Exp Med 178:2231,1993
90. Simon HU, Yousefi S, Dibbert B, Levi-Schaffer F, Blaser K: Antiapoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol 27:3536,1997
91. Clement MV, Stamenkovic I: Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J Exp Med 180:557,1994